Search
Fortress Biotech Inc
FBIOAdd to Watchlist
3.130USD
-0.160-4.86%
Close 07-31 16:00（ET）Quotes delayed by 15 min
103.87MMarket Cap
0.81P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-07-31The current earnings forecast score of Fortress Biotech Inc is 8.00, ranking 56 out of 155 in the Pharmaceuticals industry. The average price target is 10.75, with a high of 17.00 and a low of 4.50.
Analyst Rating
Based on
2
analysts
Buy
Current Rating
11.000
Target Price
+228.36%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
160
Total
6
Median
9
Average
Company name
Ratings
Analysts
Fortress Biotech Inc
FBIO
2
Amgen Inc
AMGN
37
Biogen Inc
BIIB
37
Eli Lilly and Co
LLY
34
Pfizer Inc
PFE
32
AbbVie Inc
ABBV
32
1
2
3
...
32
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FAQs
What is Fortress Biotech Inc's expected revenue for the next quarter?
Fortress Biotech Inc's expected revenue is 18.30M.
What is Fortress Biotech Inc's price target?
Analysts forecast that Fortress Biotech Inc's price target is USD 10.75, with the highest forecast at USD 17.00 and the lowest forecast at USD 4.50.
How have Fortress Biotech IncFBIO's recent earnings per share performed?
The market expectation was USD 3.44, while Fortress Biotech IncFBIO's earnings per share (EPS) for the previous quarter was USD -0.20. EPS for the next quarter is expected at USD -0.20.
What is the analyst rating for Fortress Biotech Inc?
Based on the ratings of Fortress Biotech Inc's stock from 2 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.